A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects

Exclusion Criteria

• •Any history or presence of clinically relevant illness at screening, which could interfere with the objectives of the study or the safety of the subject's participation.
• •Frequent headaches and/or migraine, recurrent nausea and/or vomiting (more than twice a month).
• •Blood donation any volume, within 2 months before inclusion.
• •Symptomatic postural hypotension.
• •Presence or history of drug hypersensitivity, or allergic disease diagnosed and treated by a physician.
• •History or presence of drug or alcohol abuse.
• •Smoking more than 5 cigarettes or equivalent per day, unable to stop smoking during the study.
• •If female, pregnancy, breast-feeding.
• •Any medication (including St John's Wort) within 14 days before inclusion or within 5 times the elimination half-life or pharmacodynamic half-life of the medication; any vaccination within the last 28 days and any biologics (antibody or its derivatives) given within 4 months before inclusion.
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.